Good Manufacturing Practices (GMP) or good manufacturing practices (BPF) for medicines

Good Manufacturing Practices (GMP) are the principles and guidelines to be observed in the manufacture of medicines for human and veterinary use.

Medicines placed on the market must obtain marketing authorization. All medicines for human or veterinary use are evaluated by an authority
competent, in order to ensure their compliance with quality, safety and efficiency requirements.

There is a manufacturing authorization system for the manufacture of medicinal products. This system guarantees that all medicines authorized on the European market are manufactured and imported only by authorized manufacturers whose activities are regularly inspected by the competent authorities and who implement the principles of drug management quality risks.

The GMPs applied to medicinal products constitute a legislative reference that can be enforced during inspections carried out in pharmaceutical companies by the competent authorities.

The pharmaceutical industry within the European Union (EU) maintains a high level of quality management in the development, manufacture and control of medicines and their active ingredients. GMPs are an essential component of the general drug quality assurance system set up by pharmaceutical companies.